Treatment of rheumatoid arthritis with Hypoxia-Inducible Factor 1alpha antagonists

Details for Australian Patent Application No. 2004294950 (hide)

Owner Entelos, Inc.

Inventors Shoda, Lisl Katharine; Wennerberg, Leif Gustaf; Defranoux, Nadine; Michelson, Seth G.; Hurez, Vincent Jacques

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004294950

PCT Pub. Number WO2005/053744

Priority 60/525,363 26.11.03 US

Filing date 24 November 2004

Wipo publication date 16 June 2005

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053744 Priority application(s): WO2005/053744

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294953-Methods and compositions for deterring abuse of opioid containing dosage forms

2004294945-Transesophageal ultrasound using a narrow probe